osimertinib,savolitinib
hutchmed,astrazeneca
['savolitinib', 'lung', 'osimertinib']
#aacr23: for more on novel approaches to overcome acquired resistance in #egfr-mutant #lungcancer, read the final analysis of the phase ib tatton trial (osimertinib + savolitinib to overcome acquired met-mediated resistance) in : 
Executive Editor of Cancer Discovery @CD_AACR, published by @AACR. @BBS_Harvard/@DanaFarber alum. Native New Yorker. Views/likes/RTs are my own. She/her